VTRS Viatris Inc.

$16.51▲ +0.79% Healthcare Other
After hours $16.45▼ -0.36% Sep 11, 7:30 PM ET
Volume 12.17M Avg Volume (10D) 7.34M
Key Metrics & Fundamentals
Market Cap
$18.96B
P/E Ratio
–
Div Yield
2.93%
52W Range
9.43 - 18.39
% vs 50 MA
-1.68%
% vs 200 MA
11.23%
RSI-14
47.5
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.74
Free Cash Flow
$322.00M
Gross Rev
$3.76B
Gross Profit
$1.46B
EBITDA
$796.40M
COGS
$2.30B
Operating Exp
$1.38B
Operating Income
$73.70M
EBIT
$73.70M
Pretax Income
-$64.00M
Net Income
-$118.80M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
Leerink Partners Initiates Viatris at Outperform With $20 Price Target
MT Newswires · Sep 9, 2026 10:47 AM
Argus Adjusts Price Target on Viatris to $20 From $18, Keeps Buy Rating
MT Newswires · Sep 8, 2026 12:07 PM
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
Insider Monkey · Sep 2, 2026 1:15 PM
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris
Zacks · Aug 31, 2026 3:10 PM
3 Cash-Producing Stocks That Concern Us
StockStory · Aug 31, 2026 1:58 PM
Viatris (VTRS) Faces Fresh Generic Earnings Questions, Is The 12% Discount Enough?
Simply Wall St. · Aug 29, 2026 8:11 AM
Cavendish reiterates 'buy' rating on Shield Therapeutics after US deal with Viatris
Proactive · Aug 28, 2026 9:15 AM
3 Generic Drug Stocks to Watch Amid Improving Industry Trends
Zacks · Aug 27, 2026 5:06 PM
The Real Engine That Could Power Tesla Stock Higher
Trefis · Aug 25, 2026 8:41 PM
Dell Stock's Massive Guidance Raise Has A Catch
Trefis · Aug 25, 2026 8:20 PM
Financial Overview - Income Statement Quarterly

See VTRS's money flow as a full page

Social Sentiment
Avg +0.60 · 2 posts
TradeDiscussionNext week's big pharma drug pricing crackdown rumors
r/options · May 9, 2025
Identified as a stock to long, likely capitalizing on the situation.
positive +0.50
NewsDiscussionHow H.R.1396 Could Impact the Stock Market (generic drugs bill)
r/wallstreetbets · Feb 17, 2025
The post directly identifies Viatris as a company that would benefit from H.R.1396.
positive +0.70
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙